The Role of Ultrasound in the Evaluation of Tardive Dyskinesia: A Case Series
References
- 1Savitt D, Jankovic J. Tardive syndromes. J. Neurol. Sci. 2018; 389: 35–42. DOI: 10.1016/j.jns.2018.02.005
- 2Moore CL, Copel JA. Point-of-care ultrasonography. N. Engl. J. Med. 2011; 364: 749–757. DOI: 10.1056/NEJMra0909487
- 3Valaikiene J, Schlachetzki F, Azevedo E, Kaps M, Lochner P, Katsanos AH, Walter U, Baracchini C, Bartels E, Školoudík D. Point-of-Care Ultrasound in Neurology – Report of the EAN SPN/ESNCH/ERcNsono Neuro-POCUS Working Group. Ultraschall Med. 2022 Aug; 43(4): 354–366. English. Epub 2022 May 5. PMID: 35512836. DOI: 10.1055/a-1816-8548
- 4Abbott S, Zelesco M, Gibson D. Tongue sonography: An introduction. Sonography [Internet]. 2020 Aug 3; 7(3): 118–25. DOI: 10.1002/sono.12230
- 5Park JE, Alter K, Hallett M. Isolated Lingual Dyskinesia in Multiple Sclerosis. JAMA Neurol. 2015; 72(10): 1196–1197. DOI: 10.1001/jamaneurol.2015.1456
- 6Yousafzai ZA, Qayyum W, Khan S, Iftikhar M, Amin QK. Case Report: Isolated Lingual Dystonia. F1000Res. 2020 Apr 30. 9: 314. PMID: 33145008; PMCID: PMC7592023. DOI: 10.12688/f1000research.23237.2
- 7Fischer A, Connor, AT, Mackenzie KM, Shaw RJ. Selective Serotonin Reuptake Inhibitors and Tardive Dyskinesia: A Case Report of Escitalopram Use in a Cardiac and Liver Transplant Patient. Journal of Clinical Psychopharmacology. 40(6): p 626–627, 11/12 2020. DOI: 10.1097/JCP.0000000000001285
- 8Yoshida K. Botulinum Neurotoxin Therapy for Lingual Dystonia Using an Individualized Injection Method Based on Clinical Features. Toxins (Basel). 2019 Jan 17. 11(1): 51. PMID: 30658420; PMCID: PMC6357149. DOI: 10.3390/toxins11010051
- 9Bledsoe IO, Viser AC, San LM. Treatment of dystonia: medications, neurotoxins, neuromodulation, and rehabilitation. Neurotherapeutics. 2020; 17(4): 1622–1644. DOI: 10.1007/s13311-020-00944-0
- 10Vasireddy RP, Sokola B, Guduru Z. New generation VMAT2 inhibitors induced parkinsonism. Clin Park Relat Disord. 2020 Nov 7. 3: 100078. PMID: 34316656; PMCID: PMC8298827. DOI: 10.1016/j.prdoa.2020.100078
- 11Duggal HS, Mendhekar DN. Risperidone-induced tardive pharyngeal dystonia presenting with persistent Dysphagia: a case report. Prim Care Companion J Clin Psychiatry. 2008; 10(2): 161–2. PMID: 18458730. PMCID: PMC2292443. DOI: 10.4088/PCC.v10n0213b
- 12Jankovic J, Roos RA. Chorea associated with Huntington’s disease: to treat or not to treat? Mov Disord. 2014 Sep 15; 29(11): 1414–8. Epub 2014 Aug 22. PMID: 25156927. DOI: 10.1002/mds.25996
- 13Fietzek UM, Nene D, Schramm A, Appel-Cresswell S, Košutzká Z, Walter U, Wissel J, Berweck S, Chouinard S, Bäumer T. The Role of Ultrasound for the Personalized Botulinum Toxin Treatment of Cervical Dystonia. Toxins (Basel). 2021 May 20; 13(5): 365. PMID: 34065. DOI: 10.3390/toxins13050365
- 14Wagle Shukla A, Herndon N, Malaty I. Case report: Lingual dystonia symptoms treated with botulinum toxin in patients with THAP1 mutation. Dystonia. 2024; 2: 11361. DOI: 10.3389/dyst.2023.11361
- 15Roy U, Srivastava AK, Cartwright MS, Panwar A, Harsh V. Muscle ultrasound as a key in assisting the diagnosis of neuromyotonia. Neuromuscul Disord. 2024 Nov 15; 46: 105243. Epub ahead of print. PMID: 39615403. DOI: 10.1016/j.nmd.2024.105243
DOI: https://doi.org/10.5334/tohm.966 | Journal eISSN: 2160-8288
Language: English
Submitted on: Oct 25, 2024
Accepted on: Jan 9, 2025
Published on: Jan 17, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2025 Ujjawal Roy, Ajay Panwar, Achal Kumar Srivastava, Michael S. Cartwright, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.